agenT-797 in Participants With Relapsed/Refractory Multiple Myeloma

Clinical trial NCT04754100 · COMPLETED

Trial details

NCT number: NCT04754100
Sponsor: MiNK Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory Multiple Myeloma

Start date: 2021-03-29
Primary completion: 2023-01-13
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.